HPRA, JAZMP inspect Divi’s Laboratories’ Unit-2 Vishakhapatnam

31 Aug 2019 Evaluate

Divi’s Laboratories’ Unit-2 Vishakhapatnam has been inspected by 5 inspectors from HPRA (Ireland) and JAZMP (Slovenia) from August 26, 2019 to August 30, 2019. The inspection at site was focused on general GMP. The inspection has concluded successfully with no critical observations.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.

Divis Lab Share Price

6305.10 -89.55 (-1.40%)
01-Jan-2026 14:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.85
Dr. Reddys Lab 1250.30
Cipla 1499.60
Zydus Lifesciences 913.35
Lupin 2101.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×